Product Code: 1946
The global exoskeleton market is slated to expand at a substantial rate through 2030 owing to the increasing incidences of strokes., In addition, the latest technological advancements in the field are likely to further fuel industry expansion over the forecast period.
Recently, key players in the sector have been working towards expanding their R&D to offer innovative technologies to their consumers, which has significantly augmented exoskeleton market growth in key regions. For instance, in May 2021, Ekso Bionics Holdings, Inc., a leader in the exoskeleton tech for industrial and medical use, extended its partnership with Kindred Healthcare, LLC to build a robotic exoskeleton dubbed the EksoNR, which is excessively used in clinics, to four Long-Term Acute Care (LTAC) Hospitals of Kindred in the United States. The multi-unit order followed the EksoNR's outstanding pilot run.
By improving patient performance in neurorehabilitation through gait training and early mobility, EksoNR has gained prominence as a usual treatment at Kindred's Inpatient Rehabilitation Hospitals. With the acquisition of these new EksoNR devices, Kindred Healthcare deepened its cooperation with Ekso Bionics and strengthened its position in acute patient services.
To cite another instance, in November 2021, the US Food and Drug Administration designated ReWalk Robotics Ltd.'s ReBoot gadget as a 'breakthrough device'. ReWalk markets and manufactures exoskeletons for people with lower limb disabilities caused by a spinal cord injury or stroke. Before exoskeletons or other assistive technologies can be extensively used, they must first receive regulatory approval.
The FDA's breakthrough device classification was a significant milestone for ReBoot as it opened the door to a more expedited review process, allowing the gadget to reach the market sooner. ReBoot, a lightweight and battery-run orthotic exosuit, works with the muscles of the affected limb to help not only maintain safe foot positioning but also push off the ground.
The exoskeleton market has been bifurcated in terms of product, application, technology, and region. Based on application, the industry has been divided into healthcare, industrial, military, and others.
The other segment accounted for a substantial market share of over 10% in 2021 and is expected to expand at a steady rate through the forecast period. Increasing concerns pertaining to musculoskeletal disorders among farmers are foreseen to escalate product uptake in the agriculture industry over the forthcoming years.
From the regional standpoint, the Latin America exoskeleton market registered a revenue share of approximately 4% in 2021 and is set to witness robust growth through 2030. Mounting adoption of advanced technologies in the field of medical devices in order to prevent spinal cord injuries is poised to bolster business growth in LATAM in the future.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Definitions & forecast parameters
- 1.1.1 Definitions
- 1.1.2 Methodology and forecast parameters
- 1.2 Impact of COVID-19, by region
- 1.2.1 North America
- 1.2.2 Europe
- 1.2.3 Asia Pacific
- 1.2.4 Latin America
- 1.2.5 MEA
- 1.3 Data Sources
- 1.3.1 Secondary
- 1.3.2 Primary
Chapter 2 Executive Summary
- 2.1 Exoskeleton industry 360 degree synopsis, 2018 - 2030
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product trends
- 2.1.4 Technology trends
- 2.1.5 Application trends
Chapter 3 Industry Insights
- 3.1 Introduction
- 3.2 Impact of COVID-19 outbreak
- 3.2.1 Global outlook
- 3.2.2 Regional impact
- 3.2.2.1 North America
- 3.2.2.2 Europe
- 3.2.2.3 Asia Pacific
- 3.2.2.4 Latin America
- 3.2.2.5 MEA
- 3.2.3 Industry value chain
- 3.2.3.1 Research & development
- 3.2.3.2 Manufacturing
- 3.2.3.3 Marketing
- 3.2.3.4 Supply
- 3.2.4 Competitive landscape
- 3.2.4.1 Strategy
- 3.2.4.2 Distribution network
- 3.2.4.3 Business growth
- 3.3 Industry ecosystem analysis
- 3.3.1 Raw material and component suppliers
- 3.3.2 Manufacturers
- 3.3.3 Marketing & distribution channel
- 3.3.4 End-use landscape
- 3.3.5 Vendor matrix
- 3.4 Impact of Ukraine- Russia war
- 3.5 Technology & innovation landscape
- 3.5.1 Thought control in exoskeleton
- 3.5.2 4D materials for exosuits
- 3.5.3 Human Universal Load Carrier (HULC)
- 3.5.4 Functional electrical stimulation (FES)
- 3.5.5 Structured functional textiles based multi-joint soft exosuits
- 3.6 Regulatory landscape
- 3.6.1 North America
- 3.6.2 Europe
- 3.6.3 Asia Pacific
- 3.6.4 Latin America
- 3.6.5 MEA
- 3.7 Investment portfolio
- 3.8 Industry impact forces
- 3.8.1 Growth drivers
- 3.8.1.1 The growing population of aging individuals across the globe
- 3.8.1.2 Growing cases of Parkinson's and other muscle-related diseases
- 3.8.1.3 Technological advancements in sensor technologies providing expanded capabilities to robotic exoskeleton
- 3.8.1.4 Upsurge in military and defense robotic exoskeletons to drive demand
- 3.8.1.5 Rising road accidents in North America to propel the demand for exoskeletons
- 3.8.2 Industry pitfalls & challenges
- 3.8.2.1 High costs associated with R&D & product acquisition
- 3.9 Growth potential analysis
- 3.10 Porter's analysis
- 3.10.1 Supplier power
- 3.10.2 Buyer power
- 3.10.3 Threat of new entrants
- 3.10.4 Threat of substitutes
- 3.10.5 Internal rivalry
- 3.11 PESTEL analysis
- 3.11.1 Political
- 3.11.2 Economic
- 3.11.3 Social
- 3.11.4 Technological
- 3.11.5 Legal
- 3.11.6 Environmental
Chapter 4 Competitive Landscape, 2021
- 4.1 Introduction
- 4.2 Company market share, 2021
- 4.3 Competitive analysis of Exoskeleton major players
- 4.3.1 Ottobock
- 4.3.2 Lockheed Martin Corporation
- 4.3.3 Parker Hannifin
- 4.3.4 Hyundai Motor Company
- 4.3.5 Bionik Laboratories Corp
- 4.4 Competitive analysis of innovative players
- 4.4.1 Hocoma
- 4.4.2 Cyberdyne Inc.
- 4.4.3 Ekso Bionics
- 4.4.4 ReWalk Robotics
- 4.4.5 Sarcos Technology and Robotics Corporation
- 4.5 Vendor adoption matrix
Chapter 5 Exoskeleton Market, By Product
- 5.1 Key trends, by product
- 5.2 Fixed/Stationary
- 5.2.1 Market estimates and forecast, 2018 - 2030
- 5.3 Mobile
- 5.3.1 Market estimates and forecast, 2018 - 2030
Chapter 6 Exoskeleton Market, By Application
- 6.1 Key trends, by application
- 6.2 Healthcare
- 6.2.1 Market estimates and forecast, 2018 - 2030
- 6.2.2 Full body
- 6.2.2.1 Market estimates and forecast, 2018 - 2030
- 6.2.3 Upper body
- 6.2.3.1 Market estimates and forecast, 2018 - 2030
- 6.2.4 Lower body
- 6.2.4.1 Market estimates and forecast, 2018 - 2030
- 6.3 Industrial
- 6.3.1 Market estimates and forecast, 2018 - 2030
- 6.3.2 Full body
- 6.3.2.1 Market estimates and forecast, 2018 - 2030
- 6.3.3 Upper body
- 6.3.3.1 Market estimates and forecast, 2018 - 2030
- 6.3.4 Lower body
- 6.3.4.1 Market estimates and forecast, 2018 - 2030
- 6.4 Military
- 6.4.1 Market estimates and forecast, 2018 - 2030
- 6.4.2 Full body
- 6.4.2.1 Market estimates and forecast, 2018 - 2030
- 6.4.3 Upper body
- 6.4.3.1 Market estimates and forecast, 2018 - 2030
- 6.4.4 Lower body
- 6.4.4.1 Market estimates and forecast, 2018 - 2030
- 6.5 Others
- 6.5.1 Market estimates and forecast, 2018 - 2030
- 6.5.2 Full body
- 6.5.2.1 Market estimates and forecast, 2018 - 2030
- 6.5.3 Upper body
- 6.5.3.1 Market estimates and forecast, 2018 - 2030
- 6.5.4 Lower body
- 6.5.4.1 Market estimates and forecast, 2018 - 2030
Chapter 7 Exoskeleton Market, By Technology
- 7.1 Key trends, by technology
- 7.2 Passive
- 7.2.1 Market estimates and forecast, 2018 - 2030
- 7.3 Semi-passive
- 7.3.1 Market estimates and forecast, 2018 - 2030
- 7.4 Active
- 7.4.1 Market estimates and forecast, 2018 - 2030
Chapter 8 Exoskeleton Market, By Region
- 8.1 Key trends, by region
- 8.2 North America
- 8.2.1 Market estimates and forecast, 2018 - 2030
- 8.2.2 Market estimates and forecast, by product, 2018 - 2030
- 8.2.3 Market estimates and forecast, by application, 2018 - 2030
- 8.2.3.1 Market estimates & forecast, by healthcare application, 2018-2030
- 8.2.3.2 Market estimates & forecast, by industrial application, 2018-2030
- 8.2.3.3 Market estimates & forecast, by military application, 2018-2030
- 8.2.3.4 Market estimates & forecast, by others application, 2018-2030
- 8.2.4 Market estimates and forecast, by technology, 2018 - 2030
Similar information is provided for
- 8.3 Europe
- 8.3.1 Market estimates and forecast, 2018 - 2030
- 8.3.2 Market estimates and forecast, by product, 2018 - 2030
- 8.3.3 Market estimates and forecast, by application, 2018 - 2030
- 8.3.3.1 Market estimates & forecast, by healthcare application, 2018-2030
- 8.3.3.2 Market estimates & forecast, by industrial application, 2018-2030
- 8.3.3.3 Market estimates & forecast, by military application, 2018-2030
- 8.3.3.4 Market estimates & forecast, by others application, 2018-2030
- 8.3.4 Market estimates and forecast, by technology, 2018 - 2030
Similar information is provided for
- 8.3.5 UK
- 8.3.6 Germany
- 8.3.7 France
- 8.3.8 Russia
- 8.4 Asia Pacific
- 8.4.1 Market estimates and forecast, 2018 - 2030
- 8.4.2 Market estimates and forecast, by product, 2018 - 2030
- 8.4.3 Market estimates and forecast, by application, 2018 - 2030
- 8.4.3.1 Market estimates & forecast, by healthcare application, 2018-2030
- 8.4.3.2 Market estimates & forecast, by industrial application, 2018-2030
- 8.4.3.3 Market estimates & forecast, by military application, 2018-2030
- 8.4.3.4 Market estimates & forecast, by others application, 2018-2030
- 8.4.4 Market estimates and forecast, by technology, 2018 - 2030
Similar information is provided for
- 8.4.5 China
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Singapore
- 8.4.9 Australia
- 8.5 Latin America
- 8.5.1 Market estimates and forecast, 2018 - 2030
- 8.5.2 Market estimates and forecast, by product, 2018 - 2030
- 8.5.3 Market estimates and forecast, by application, 2018 - 2030
- 8.5.3.1 Market estimates & forecast, by healthcare application, 2018-2030
- 8.5.3.2 Market estimates & forecast, by industrial application, 2018-2030
- 8.5.3.3 Market estimates & forecast, by military application, 2018-2030
- 8.5.3.4 Market estimates & forecast, by others application, 2018-2030
- 8.5.4 Market estimates and forecast, by technology, 2018 - 2030
Similar information is provided for
- 8.5.5 Brazil
- 8.5.6 Mexico
- 8.6 MEA
- 8.6.1 Market estimates and forecast, 2018 - 2030
- 8.6.2 Market estimates and forecast, by product, 2018 - 2030
- 8.6.3 Market estimates and forecast, by application, 2018 - 2030
- 8.6.3.1 Market estimates & forecast, by healthcare application, 2018-2030
- 8.6.3.2 Market estimates & forecast, by industrial application, 2018-2030
- 8.6.3.3 Market estimates & forecast, by military application, 2018-2030
- 8.6.3.4 Market estimates & forecast, by others application, 2018-2030
- 8.6.4 Market estimates and forecast, by technology, 2018 - 2030
Chapter 9 Company Profiles
- 9.1 Bionik Laboratories Corp.
- 9.1.1 Business Overview
- 9.1.2 Financial Data
- 9.1.3 Product Landscape
- 9.1.4 Strategic Outlook
- 9.1.5 SWOT Analysis
- 9.2 B-Temia
- 9.2.1 Business Overview
- 9.2.2 Financial Data
- 9.2.3 Product Landscape
- 9.2.4 Strategic Outlook
- 9.2.5 SWOT Analysis
- 9.3 Cyberdyne Inc.
- 9.3.1 Business Overview
- 9.3.2 Financial Data
- 9.3.3 Product Landscape
- 9.3.4 Strategic Outlook
- 9.3.5 SWOT Analysis
- 9.4 Ekso Bionics
- 9.4.1 Business Overview
- 9.4.2 Financial Data
- 9.4.3 Product Landscape
- 9.4.4 Strategic Outlook
- 9.4.5 SWOT Analysis
- 9.5 Gogoa
- 9.5.1 Business Overview
- 9.5.2 Financial Data
- 9.5.3 Product Landscape
- 9.5.4 Strategic Outlook
- 9.5.5 SWOT Analysis
- 9.6 Hocoma
- 9.6.1 Business Overview
- 9.6.2 Financial Data
- 9.6.3 Product Landscape
- 9.6.4 Strategic Outlook
- 9.6.5 SWOT Analysis
- 9.7 Hyundai Motor Company
- 9.7.1 Business Overview
- 9.7.2 Financial Data
- 9.7.3 Product Landscape
- 9.7.4 Strategic Outlook
- 9.7.5 SWOT Analysis
- 9.8 Levitate Technologies, Inc.
- 9.8.1 Business Overview
- 9.8.2 Financial Data
- 9.8.3 Product Landscape
- 9.8.4 Strategic Outlook
- 9.8.5 SWOT Analysis
- 9.9 Lockheed Martin Corporation
- 9.9.1 Business Overview
- 9.9.2 Financial Data
- 9.9.3 Product Landscape
- 9.9.4 Strategic Outlook
- 9.9.5 SWOT Analysis
- 9.10 Noonee
- 9.10.1 Business Overview
- 9.10.2 Financial Data
- 9.10.3 Product Landscape
- 9.10.4 Strategic Outlook
- 9.10.5 SWOT Analysis
- 9.11 Ottobock SE & Co. KGaA
- 9.11.1 Business Overview
- 9.11.2 Financial Data
- 9.11.3 Product Landscape
- 9.11.4 Strategic Outlook
- 9.11.5 SWOT Analysis
- 9.12 Parker Hannifin
- 9.12.1 Business Overview
- 9.12.2 Financial Data
- 9.12.3 Product Landscape
- 9.12.4 Strategic Outlook
- 9.12.5 SWOT Analysis
- 9.13 ReWalk Robotics
- 9.13.1 Business Overview
- 9.13.2 Financial Data
- 9.13.3 Product Landscape
- 9.13.4 Strategic Outlook
- 9.13.5 SWOT Analysis
- 9.14 REX Bionics
- 9.14.1 Business Overview
- 9.14.2 Financial Data
- 9.14.3 Product Landscape
- 9.14.4 Strategic Outlook
- 9.14.5 SWOT Analysis
- 9.15 Sarcos
- 9.15.1 Business Overview
- 9.15.2 Financial Data
- 9.15.3 Product Landscape
- 9.15.4 Strategic Outlook
- 9.15.5 SWOT Analysis
- 9.16 Technaid S.L.
- 9.16.1 Business Overview
- 9.16.2 Financial Data
- 9.16.3 Product Landscape
- 9.16.4 Strategic Outlook
- 9.16.5 SWOT Analysis